0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mycoplasma Testing in Clinical Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-21V994
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mycoplasma Testing in Clinical Market Insights Forecast to 2028
BUY CHAPTERS

Global Mycoplasma Testing in Clinical Market Insights, Forecast to 2030

Code: QYRE-Auto-21V994
Report
December 2024
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mycoplasma Testing in Clinical Market

This report studies the Mycoplasma Testing in Clinical, the only way to confirm mycoplasma contamination is by routine testing using one or more special techniques, including direct growth on broth/agar, specific DNA staining, PCR, ELISA, RNA labeling and enzymatic procedures.
Market Analysis and Insights: Global Mycoplasma Testing in Clinical Market
The global Mycoplasma Testing in Clinical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Mycoplasma Testing in Clinical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Mycoplasma Testing in Clinical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Mycoplasma Testing in Clinical is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Mycoplasma Testing in Clinical include Sartorius AG, MERCK KGAA, ELITechGROUP, Bio-Rad Laboratories, Inc., Eurofins Scientific, Minerva Biolabs, Charles River, Clongen Laboratories and BioFire Diagnostics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Mycoplasma Testing in Clinical is widely used in various fields, such as Cell Line Testing, Virus Testing and Others,, etc. Cell Line Testing provides greatest supports to the Mycoplasma Testing in Clinical industry development. In 2023, global % revenue of Mycoplasma Testing in Clinical went into Cell Line Testing filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Mycoplasma Testing in Clinical market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mycoplasma Testing in Clinical, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Mycoplasma Testing in Clinical, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mycoplasma Testing in Clinical revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Mycoplasma Testing in Clinical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Mycoplasma Testing in Clinical revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Mycoplasma Testing in Clinical Market Report

Report Metric Details
Report Name Mycoplasma Testing in Clinical Market
Segment by Type
Segment by Application
  • Cell Line Testing
  • Virus Testing
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sartorius AG, MERCK KGAA, ELITechGROUP, Bio-Rad Laboratories, Inc., Eurofins Scientific, Minerva Biolabs, Charles River, Clongen Laboratories, BioFire Diagnostics, PromoCell GmbH, Lonza, Roche, Agilent Technologies, Inc., Liofilchem Srl, ZEAKON Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Mycoplasma Testing in Clinical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Mycoplasma Testing in Clinical companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mycoplasma Testing in Clinical revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Mycoplasma Testing in Clinical Market report?

Ans: The main players in the Mycoplasma Testing in Clinical Market are Sartorius AG, MERCK KGAA, ELITechGROUP, Bio-Rad Laboratories, Inc., Eurofins Scientific, Minerva Biolabs, Charles River, Clongen Laboratories, BioFire Diagnostics, PromoCell GmbH, Lonza, Roche, Agilent Technologies, Inc., Liofilchem Srl, ZEAKON Diagnostics

What are the Application segmentation covered in the Mycoplasma Testing in Clinical Market report?

Ans: The Applications covered in the Mycoplasma Testing in Clinical Market report are Cell Line Testing, Virus Testing, Others

What are the Type segmentation covered in the Mycoplasma Testing in Clinical Market report?

Ans: The Types covered in the Mycoplasma Testing in Clinical Market report are PCR, ELSA, Enzymatic Methods, DNA Staining

Recommended Reports

Clinical Diagnostic Testing

Infectious Disease Testing

Mycoplasma & PCR Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 ELSA
1.2.4 Enzymatic Methods
1.2.5 DNA Staining
1.3 Market by Application
1.3.1 Global Mycoplasma Testing in Clinical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cell Line Testing
1.3.3 Virus Testing
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mycoplasma Testing in Clinical Market Perspective (2019-2030)
2.2 Global Mycoplasma Testing in Clinical Growth Trends by Region
2.2.1 Mycoplasma Testing in Clinical Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mycoplasma Testing in Clinical Historic Market Size by Region (2019-2024)
2.2.3 Mycoplasma Testing in Clinical Forecasted Market Size by Region (2025-2030)
2.3 Mycoplasma Testing in Clinical Market Dynamics
2.3.1 Mycoplasma Testing in Clinical Industry Trends
2.3.2 Mycoplasma Testing in Clinical Market Drivers
2.3.3 Mycoplasma Testing in Clinical Market Challenges
2.3.4 Mycoplasma Testing in Clinical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Mycoplasma Testing in Clinical by Players
3.1.1 Global Mycoplasma Testing in Clinical Revenue by Players (2019-2024)
3.1.2 Global Mycoplasma Testing in Clinical Revenue Market Share by Players (2019-2024)
3.2 Global Mycoplasma Testing in Clinical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Mycoplasma Testing in Clinical, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Mycoplasma Testing in Clinical Market Concentration Ratio
3.4.1 Global Mycoplasma Testing in Clinical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycoplasma Testing in Clinical Revenue in 2023
3.5 Global Key Players of Mycoplasma Testing in Clinical Head office and Area Served
3.6 Global Key Players of Mycoplasma Testing in Clinical, Product and Application
3.7 Global Key Players of Mycoplasma Testing in Clinical, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycoplasma Testing in Clinical Breakdown Data by Type
4.1 Global Mycoplasma Testing in Clinical Historic Market Size by Type (2019-2024)
4.2 Global Mycoplasma Testing in Clinical Forecasted Market Size by Type (2025-2030)
5 Mycoplasma Testing in Clinical Breakdown Data by Application
5.1 Global Mycoplasma Testing in Clinical Historic Market Size by Application (2019-2024)
5.2 Global Mycoplasma Testing in Clinical Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mycoplasma Testing in Clinical Market Size (2019-2030)
6.2 North America Mycoplasma Testing in Clinical Market Size by Type
6.2.1 North America Mycoplasma Testing in Clinical Market Size by Type (2019-2024)
6.2.2 North America Mycoplasma Testing in Clinical Market Size by Type (2025-2030)
6.2.3 North America Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
6.3 North America Mycoplasma Testing in Clinical Market Size by Application
6.3.1 North America Mycoplasma Testing in Clinical Market Size by Application (2019-2024)
6.3.2 North America Mycoplasma Testing in Clinical Market Size by Application (2025-2030)
6.3.3 North America Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
6.4 North America Mycoplasma Testing in Clinical Market Size by Country
6.4.1 North America Mycoplasma Testing in Clinical Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Mycoplasma Testing in Clinical Market Size by Country (2019-2024)
6.4.3 North America Mycoplasma Testing in Clinical Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Mycoplasma Testing in Clinical Market Size (2019-2030)
7.2 Europe Mycoplasma Testing in Clinical Market Size by Type
7.2.1 Europe Mycoplasma Testing in Clinical Market Size by Type (2019-2024)
7.2.2 Europe Mycoplasma Testing in Clinical Market Size by Type (2025-2030)
7.2.3 Europe Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
7.3 Europe Mycoplasma Testing in Clinical Market Size by Application
7.3.1 Europe Mycoplasma Testing in Clinical Market Size by Application (2019-2024)
7.3.2 Europe Mycoplasma Testing in Clinical Market Size by Application (2025-2030)
7.3.3 Europe Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
7.4 Europe Mycoplasma Testing in Clinical Market Size by Country
7.4.1 Europe Mycoplasma Testing in Clinical Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Mycoplasma Testing in Clinical Market Size by Country (2019-2024)
7.4.3 Europe Mycoplasma Testing in Clinical Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Mycoplasma Testing in Clinical Market Size (2019-2030)
8.2 China Mycoplasma Testing in Clinical Market Size by Type
8.2.1 China Mycoplasma Testing in Clinical Market Size by Type (2019-2024)
8.2.2 China Mycoplasma Testing in Clinical Market Size by Type (2025-2030)
8.2.3 China Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
8.3 China Mycoplasma Testing in Clinical Market Size by Application
8.3.1 China Mycoplasma Testing in Clinical Market Size by Application (2019-2024)
8.3.2 China Mycoplasma Testing in Clinical Market Size by Application (2025-2030)
8.3.3 China Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Mycoplasma Testing in Clinical Market Size (2019-2030)
9.2 Asia Mycoplasma Testing in Clinical Market Size by Type
9.2.1 Asia Mycoplasma Testing in Clinical Market Size by Type (2019-2024)
9.2.2 Asia Mycoplasma Testing in Clinical Market Size by Type (2025-2030)
9.2.3 Asia Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
9.3 Asia Mycoplasma Testing in Clinical Market Size by Application
9.3.1 Asia Mycoplasma Testing in Clinical Market Size by Application (2019-2024)
9.3.2 Asia Mycoplasma Testing in Clinical Market Size by Application (2025-2030)
9.3.3 Asia Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
9.4 Asia Mycoplasma Testing in Clinical Market Size by Region
9.4.1 Asia Mycoplasma Testing in Clinical Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Mycoplasma Testing in Clinical Market Size by Region (2019-2024)
9.4.3 Asia Mycoplasma Testing in Clinical Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Type
10.2.1 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Application
10.3.1 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Country
10.4.1 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sartorius AG
11.1.1 Sartorius AG Company Details
11.1.2 Sartorius AG Business Overview
11.1.3 Sartorius AG Mycoplasma Testing in Clinical Introduction
11.1.4 Sartorius AG Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.1.5 Sartorius AG Recent Developments
11.2 MERCK KGAA
11.2.1 MERCK KGAA Company Details
11.2.2 MERCK KGAA Business Overview
11.2.3 MERCK KGAA Mycoplasma Testing in Clinical Introduction
11.2.4 MERCK KGAA Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.2.5 MERCK KGAA Recent Developments
11.3 ELITechGROUP
11.3.1 ELITechGROUP Company Details
11.3.2 ELITechGROUP Business Overview
11.3.3 ELITechGROUP Mycoplasma Testing in Clinical Introduction
11.3.4 ELITechGROUP Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.3.5 ELITechGROUP Recent Developments
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Details
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.4.5 Bio-Rad Laboratories, Inc. Recent Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Mycoplasma Testing in Clinical Introduction
11.5.4 Eurofins Scientific Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.5.5 Eurofins Scientific Recent Developments
11.6 Minerva Biolabs
11.6.1 Minerva Biolabs Company Details
11.6.2 Minerva Biolabs Business Overview
11.6.3 Minerva Biolabs Mycoplasma Testing in Clinical Introduction
11.6.4 Minerva Biolabs Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.6.5 Minerva Biolabs Recent Developments
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River Mycoplasma Testing in Clinical Introduction
11.7.4 Charles River Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.7.5 Charles River Recent Developments
11.8 Clongen Laboratories
11.8.1 Clongen Laboratories Company Details
11.8.2 Clongen Laboratories Business Overview
11.8.3 Clongen Laboratories Mycoplasma Testing in Clinical Introduction
11.8.4 Clongen Laboratories Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.8.5 Clongen Laboratories Recent Developments
11.9 BioFire Diagnostics
11.9.1 BioFire Diagnostics Company Details
11.9.2 BioFire Diagnostics Business Overview
11.9.3 BioFire Diagnostics Mycoplasma Testing in Clinical Introduction
11.9.4 BioFire Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.9.5 BioFire Diagnostics Recent Developments
11.10 PromoCell GmbH
11.10.1 PromoCell GmbH Company Details
11.10.2 PromoCell GmbH Business Overview
11.10.3 PromoCell GmbH Mycoplasma Testing in Clinical Introduction
11.10.4 PromoCell GmbH Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.10.5 PromoCell GmbH Recent Developments
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Mycoplasma Testing in Clinical Introduction
11.11.4 Lonza Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.11.5 Lonza Recent Developments
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Mycoplasma Testing in Clinical Introduction
11.12.4 Roche Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.12.5 Roche Recent Developments
11.13 Agilent Technologies, Inc.
11.13.1 Agilent Technologies, Inc. Company Details
11.13.2 Agilent Technologies, Inc. Business Overview
11.13.3 Agilent Technologies, Inc. Mycoplasma Testing in Clinical Introduction
11.13.4 Agilent Technologies, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.13.5 Agilent Technologies, Inc. Recent Developments
11.14 Liofilchem Srl
11.14.1 Liofilchem Srl Company Details
11.14.2 Liofilchem Srl Business Overview
11.14.3 Liofilchem Srl Mycoplasma Testing in Clinical Introduction
11.14.4 Liofilchem Srl Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.14.5 Liofilchem Srl Recent Developments
11.15 ZEAKON Diagnostics
11.15.1 ZEAKON Diagnostics Company Details
11.15.2 ZEAKON Diagnostics Business Overview
11.15.3 ZEAKON Diagnostics Mycoplasma Testing in Clinical Introduction
11.15.4 ZEAKON Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024)
11.15.5 ZEAKON Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of PCR
    Table 3. Key Players of ELSA
    Table 4. Key Players of Enzymatic Methods
    Table 5. Key Players of DNA Staining
    Table 6. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Mycoplasma Testing in Clinical Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Mycoplasma Testing in Clinical Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Mycoplasma Testing in Clinical Market Share by Region (2019-2024)
    Table 10. Global Mycoplasma Testing in Clinical Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Mycoplasma Testing in Clinical Market Share by Region (2025-2030)
    Table 12. Mycoplasma Testing in Clinical Market Trends
    Table 13. Mycoplasma Testing in Clinical Market Drivers
    Table 14. Mycoplasma Testing in Clinical Market Challenges
    Table 15. Mycoplasma Testing in Clinical Market Restraints
    Table 16. Global Mycoplasma Testing in Clinical Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Mycoplasma Testing in Clinical Revenue Share by Players (2019-2024)
    Table 18. Global Top Mycoplasma Testing in Clinical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing in Clinical as of 2023)
    Table 19. Global Mycoplasma Testing in Clinical Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Mycoplasma Testing in Clinical Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Mycoplasma Testing in Clinical, Headquarters and Area Served
    Table 22. Global Key Players of Mycoplasma Testing in Clinical, Product and Application
    Table 23. Global Key Players of Mycoplasma Testing in Clinical, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Mycoplasma Testing in Clinical Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2019-2024)
    Table 27. Global Mycoplasma Testing in Clinical Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2025-2030)
    Table 29. Global Mycoplasma Testing in Clinical Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Mycoplasma Testing in Clinical Revenue Share by Application (2019-2024)
    Table 31. Global Mycoplasma Testing in Clinical Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Mycoplasma Testing in Clinical Revenue Share by Application (2025-2030)
    Table 33. North America Mycoplasma Testing in Clinical Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Mycoplasma Testing in Clinical Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Mycoplasma Testing in Clinical Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Mycoplasma Testing in Clinical Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Mycoplasma Testing in Clinical Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Mycoplasma Testing in Clinical Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Mycoplasma Testing in Clinical Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Mycoplasma Testing in Clinical Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Mycoplasma Testing in Clinical Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Mycoplasma Testing in Clinical Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Mycoplasma Testing in Clinical Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Mycoplasma Testing in Clinical Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Mycoplasma Testing in Clinical Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Mycoplasma Testing in Clinical Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Mycoplasma Testing in Clinical Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Mycoplasma Testing in Clinical Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Mycoplasma Testing in Clinical Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Mycoplasma Testing in Clinical Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Mycoplasma Testing in Clinical Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Mycoplasma Testing in Clinical Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Mycoplasma Testing in Clinical Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Mycoplasma Testing in Clinical Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Mycoplasma Testing in Clinical Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Mycoplasma Testing in Clinical Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Mycoplasma Testing in Clinical Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Sartorius AG Company Details
    Table 66. Sartorius AG Business Overview
    Table 67. Sartorius AG Mycoplasma Testing in Clinical Product
    Table 68. Sartorius AG Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 69. Sartorius AG Recent Developments
    Table 70. MERCK KGAA Company Details
    Table 71. MERCK KGAA Business Overview
    Table 72. MERCK KGAA Mycoplasma Testing in Clinical Product
    Table 73. MERCK KGAA Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 74. MERCK KGAA Recent Developments
    Table 75. ELITechGROUP Company Details
    Table 76. ELITechGROUP Business Overview
    Table 77. ELITechGROUP Mycoplasma Testing in Clinical Product
    Table 78. ELITechGROUP Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 79. ELITechGROUP Recent Developments
    Table 80. Bio-Rad Laboratories, Inc. Company Details
    Table 81. Bio-Rad Laboratories, Inc. Business Overview
    Table 82. Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Product
    Table 83. Bio-Rad Laboratories, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 84. Bio-Rad Laboratories, Inc. Recent Developments
    Table 85. Eurofins Scientific Company Details
    Table 86. Eurofins Scientific Business Overview
    Table 87. Eurofins Scientific Mycoplasma Testing in Clinical Product
    Table 88. Eurofins Scientific Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 89. Eurofins Scientific Recent Developments
    Table 90. Minerva Biolabs Company Details
    Table 91. Minerva Biolabs Business Overview
    Table 92. Minerva Biolabs Mycoplasma Testing in Clinical Product
    Table 93. Minerva Biolabs Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 94. Minerva Biolabs Recent Developments
    Table 95. Charles River Company Details
    Table 96. Charles River Business Overview
    Table 97. Charles River Mycoplasma Testing in Clinical Product
    Table 98. Charles River Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 99. Charles River Recent Developments
    Table 100. Clongen Laboratories Company Details
    Table 101. Clongen Laboratories Business Overview
    Table 102. Clongen Laboratories Mycoplasma Testing in Clinical Product
    Table 103. Clongen Laboratories Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 104. Clongen Laboratories Recent Developments
    Table 105. BioFire Diagnostics Company Details
    Table 106. BioFire Diagnostics Business Overview
    Table 107. BioFire Diagnostics Mycoplasma Testing in Clinical Product
    Table 108. BioFire Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 109. BioFire Diagnostics Recent Developments
    Table 110. PromoCell GmbH Company Details
    Table 111. PromoCell GmbH Business Overview
    Table 112. PromoCell GmbH Mycoplasma Testing in Clinical Product
    Table 113. PromoCell GmbH Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 114. PromoCell GmbH Recent Developments
    Table 115. Lonza Company Details
    Table 116. Lonza Business Overview
    Table 117. Lonza Mycoplasma Testing in Clinical Product
    Table 118. Lonza Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 119. Lonza Recent Developments
    Table 120. Roche Company Details
    Table 121. Roche Business Overview
    Table 122. Roche Mycoplasma Testing in Clinical Product
    Table 123. Roche Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 124. Roche Recent Developments
    Table 125. Agilent Technologies, Inc. Company Details
    Table 126. Agilent Technologies, Inc. Business Overview
    Table 127. Agilent Technologies, Inc. Mycoplasma Testing in Clinical Product
    Table 128. Agilent Technologies, Inc. Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 129. Agilent Technologies, Inc. Recent Developments
    Table 130. Liofilchem Srl Company Details
    Table 131. Liofilchem Srl Business Overview
    Table 132. Liofilchem Srl Mycoplasma Testing in Clinical Product
    Table 133. Liofilchem Srl Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 134. Liofilchem Srl Recent Developments
    Table 135. ZEAKON Diagnostics Company Details
    Table 136. ZEAKON Diagnostics Business Overview
    Table 137. ZEAKON Diagnostics Mycoplasma Testing in Clinical Product
    Table 138. ZEAKON Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2019-2024) & (US$ Million)
    Table 139. ZEAKON Diagnostics Recent Developments
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Mycoplasma Testing in Clinical Market Share by Type: 2023 VS 2030
    Figure 3. PCR Features
    Figure 4. ELSA Features
    Figure 5. Enzymatic Methods Features
    Figure 6. DNA Staining Features
    Figure 7. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Mycoplasma Testing in Clinical Market Share by Application: 2023 VS 2030
    Figure 9. Cell Line Testing Case Studies
    Figure 10. Virus Testing Case Studies
    Figure 11. Others Case Studies
    Figure 12. Mycoplasma Testing in Clinical Report Years Considered
    Figure 13. Global Mycoplasma Testing in Clinical Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Mycoplasma Testing in Clinical Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Mycoplasma Testing in Clinical Market Share by Region: 2023 VS 2030
    Figure 16. Global Mycoplasma Testing in Clinical Market Share by Players in 2023
    Figure 17. Global Top Mycoplasma Testing in Clinical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing in Clinical as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Mycoplasma Testing in Clinical Revenue in 2023
    Figure 19. North America Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
    Figure 21. North America Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
    Figure 22. North America Mycoplasma Testing in Clinical Market Share by Country (2019-2030)
    Figure 23. United States Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Mycoplasma Testing in Clinical Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
    Figure 27. Europe Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
    Figure 28. Europe Mycoplasma Testing in Clinical Market Share by Country (2019-2030)
    Figure 29. Germany Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Mycoplasma Testing in Clinical Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
    Figure 37. China Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
    Figure 38. Asia Mycoplasma Testing in Clinical Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
    Figure 40. Asia Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
    Figure 41. Asia Mycoplasma Testing in Clinical Market Share by Region (2019-2030)
    Figure 42. Japan Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Mycoplasma Testing in Clinical Market Share by Country (2019-2030)
    Figure 52. Brazil Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Mycoplasma Testing in Clinical Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Sartorius AG Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 59. MERCK KGAA Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 60. ELITechGROUP Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 61. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 62. Eurofins Scientific Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 63. Minerva Biolabs Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 64. Charles River Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 65. Clongen Laboratories Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 66. BioFire Diagnostics Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 67. PromoCell GmbH Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 68. Lonza Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 69. Roche Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 70. Agilent Technologies, Inc. Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 71. Liofilchem Srl Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 72. ZEAKON Diagnostics Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS